189 related articles for article (PubMed ID: 34610336)
1. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
4. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
5. Combination of nicotinamide mononucleotide and troxerutin induces full protection against doxorubicin-induced cardiotoxicity by modulating mitochondrial biogenesis and inflammatory response.
Khosroshahi AJ; Mokhtari B; Badalzadeh R
Mol Biol Rep; 2022 Sep; 49(9):8209-8218. PubMed ID: 35842854
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
7. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
Zhang YY; Yi M; Huang YP
Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative Effect of Cardamom Aqueous Extract on Doxorubicin-Induced Cardiotoxicity in Rats.
Abu Gazia M; El-Magd MA
Cells Tissues Organs; 2018; 206(1-2):62-72. PubMed ID: 30716735
[TBL] [Abstract][Full Text] [Related]
9. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
[TBL] [Abstract][Full Text] [Related]
11. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
Shaker RA; Abboud SH; Assad HC; Hadi N
BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
13. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice.
Alzokaky AA; Al-Karmalawy AA; Saleh MA; Abdo W; Farage AE; Belal A; Abourehab MAS; Antar SA
Life Sci; 2023 Mar; 316():121390. PubMed ID: 36649752
[TBL] [Abstract][Full Text] [Related]
15. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
16. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
[TBL] [Abstract][Full Text] [Related]
18. Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome.
Shi W; Chen J; Zhao N; Xing Y; Liu S; Chen M; Fang W; Zhang T; Li L; Zhang H; Zhang M; Zeng X; Chen S; Wang S; Xie S; Deng W
J Mol Cell Cardiol; 2024 Jan; 186():81-93. PubMed ID: 37995517
[TBL] [Abstract][Full Text] [Related]
19. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
Khafaga AF; El-Sayed YS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
